Cargando…

COVID-19 and systemic anticancer therapy: exploiting uncertainty

Detalles Bibliográficos
Autores principales:	Gelderblom, Hans, Veelken, Hendrik, Stiggelbout, Anne M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836221/ https://www.ncbi.nlm.nih.gov/pubmed/33253642 http://dx.doi.org/10.1016/S1470-2045(20)30700-2

Ejemplares similares

Exploiting an early immunological window of opportunity in COVID-19
por: Russell, Clark D
Publicado: (2021)

Dexamethasone in hospitalised patients with COVID-19: addressing uncertainties
por: Matthay, Michael A, et al.
Publicado: (2020)

COVID-19 vaccine effectiveness in patients with cancer: remaining vulnerabilities and uncertainties
por: Kuderer, Nicole M, et al.
Publicado: (2022)

COVID-19, uncertainty, and moral experiments
por: Klenk, Michael, et al.
Publicado: (2021)

Preparing for uncertainty: endemic paediatric viral illnesses after COVID-19 pandemic disruption
por: Messacar, Kevin, et al.
Publicado: (2022)

Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy
por: Saini, Kamal S., et al.
Publicado: (2020)

COVID-19 vaccination advice via SMS-based video to improve vaccination uncertainty in at-risk groups
por: Bateman, James, et al.
Publicado: (2021)

Exploiting lipotoxicity for the treatment of liver cancer
por: Rudalska, Ramona, et al.
Publicado: (2021)

SCRaMbLEing to understand and exploit structural variation in genomes
por: Steensels, Jan, et al.
Publicado: (2018)

Making policy decisions under plural uncertainty: responding to the COVID-19 pandemic
por: Ongaro, Malvina
Publicado: (2021)

Sensitivity and specificity in prevalence studies: The importance of considering uncertainty
por: Izbicki, Rafael, et al.
Publicado: (2020)

Error, reproducibility and uncertainty in experiments for electrochemical energy technologies
por: Smith, Graham, et al.
Publicado: (2022)

Intravenous immunoglobulin therapy for COVID-19 ARDS
por: Wilfong, Erin M, et al.
Publicado: (2022)

Passive antibody therapy in COVID-19
por: Abraham, Jonathan
Publicado: (2020)

COVID-19 and the cardiovascular system
por: Zheng, Ying-Ying, et al.
Publicado: (2020)

CD24Fc: an emerging COVID-19 therapy
por: Eckhardt, Christina M, et al.
Publicado: (2022)

COVID-19 and the endocrine system: exploring the unexplored
por: Pal, R., et al.
Publicado: (2020)

COVID-19: immunopathology and its implications for therapy
por: Cao, Xuetao
Publicado: (2020)

The opening salvo of anti-complement therapy against COVID-19
por: Campbell, Courtney M
Publicado: (2020)

Exploiting tumor cell senescence in anticancer therapy
por: Lee, Minyoung, et al.
Publicado: (2014)

COVID-19: organoids go viral
por: Clevers, Hans
Publicado: (2020)

Reordering gender systems: can COVID-19 lead to improved gender equality and health?
por: King, Tania, et al.
Publicado: (2020)

Electroconvulsive therapy practice during the COVID-19 pandemic
por: Bellini, Helena, et al.
Publicado: (2020)

Convalescent plasma as a potential therapy for COVID-19
por: Chen, Long, et al.
Publicado: (2020)

Kidney involvement in COVID-19 and rationale for extracorporeal therapies
por: Ronco, Claudio, et al.
Publicado: (2020)

No perfect therapy for the imperfect COVID-19 cytokine storm
por: Cron, Randy Q
Publicado: (2022)

COVID-19: ACT trials for colchicine and antithrombotic therapies
por: Barco, Stefano, et al.
Publicado: (2022)

COVID-19 and the future of food systems at the UNFCCC
por: Gralak, Sylvia, et al.
Publicado: (2020)

COVID-19 and management of neuroimmunological disorders
por: Hartung, Hans-Peter, et al.
Publicado: (2020)

Off-label therapy targeting pathogenic inflammation in COVID-19
por: Romani, Luigina, et al.
Publicado: (2020)

Challenges in lung cancer therapy during the COVID-19 pandemic
por: Calabrò, Luana, et al.
Publicado: (2020)

Who, what, and when—effective therapy for severe COVID-19
por: Kelmenson, Daniel A, et al.
Publicado: (2022)

Babies before bottom lines: A call for Australia to end exploitative marketing of commercial milk formula at home and abroad
por: Munzer, Madeleine, et al.
Publicado: (2022)

COVID-19 vaccines for the European region: an unprecedented challenge
por: Kluge, Hans, et al.
Publicado: (2021)

Is IL-6 a key cytokine target for therapy in COVID-19?
por: Jones, Simon A., et al.
Publicado: (2021)

Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic
por: South, Andrew M., et al.
Publicado: (2020)

COVID-19 and the other pandemic: populations made vulnerable by systemic inequity
por: Gray, Darrell M., et al.
Publicado: (2020)

COVID-19: the vasculature unleashed
por: Teuwen, Laure-Anne, et al.
Publicado: (2020)

Are high-performing health systems resilient against the COVID-19 epidemic?
por: Legido-Quigley, Helena, et al.
Publicado: (2020)

Effect of the COVID-19 pandemic on patients with systemic rheumatic diseases
por: Antonelli, Alessandro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jbphct9qab1qdfi95dn8rgosuk